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Protein complexes are dynamic. A new analysis of two
quantitative proteomic datasets reveals cell type-specific
changes in the stoichiometry of complexes, which
often involve paralog switching.that is required for embryonic stem cell maintenanceIntroduction
The function of a protein is often tied to its interactions,
and many proteins function as components of large
multiprotein complexes. Multiprotein complexes also
will connect to each other in a cell to carry out coor-
dinated biological functions. Every cell has a network of
protein interactions, where these connections within and
between proteins and complexes yield insights into cel-
lular states. Large-scale studies have been conducted to
define human protein interaction networks through the
analysis of thousands of affinity purifications in multiple
cell types. Two recent studies by Huttlin and colleagues,
and Hein et al., have reported human interactomes con-
structed using data from HEK293T cells [1], and HeLa
cells [2], respectively. Both of these studies reported
thousands of protein interactions, presenting one picture
of protein interaction networks and topology in these
different cell types.
There is certainly value in these types of analyses, in
which, for example, new interactions of disease-related
proteins can be found and characterized [1]. However,
there is no single, fixed human interactome. Instead, it is
likely that the number of interaction networks might
number in the thousands, perhaps even an infinite num-
ber. Protein complexes and interaction networks are
context specific—an example is the different forms of
the Mediator protein complex that are differentiated and
dependent on the specific bait protein used for affinity
purification [3]. Additionally, protein complexes are
dynamic, and differ across cell types and according toCorrespondence: mpw@stowers.org
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alter specific protein interaction networks [4]. Special-
ized ribosomes, which vary in their subunit composition,
are emerging as key regulators of embryonic develop-
ment [5]. The mammalian SWI/SNF protein complex
(also named BAF) has a dedicated subunit composition
and pluripotency [6]. The above are just some examples
of multiple studies that support the claim that there is
no single human interactome.
Analyses of interaction networks are multidisciplinary
efforts. In most of the papers mentioned above, compu-
tational biologists, biochemists, cell biologists and prote-
omics scientists were needed to perform the studies.
These studies are often classified as ‘systems biology’, but
this classification sometimes obscures the diverse range
of skills needed to undertake these studies. For example,
in 2013 a group at the European Molecular Biology
Laboratory (EMBL) collaborated to analyze human
nuclear pore complexes [7]. This integrated effort led to
the discovery that the composition and stoichiometry of
nuclear pore complexes varies across human cell lines.
The collaborators proposed three different possible sce-
narios to explain their results: stoichiometric changes,
subunit switching or competing interfaces [7]. The ana-
lyses of individual complexes such as SWI/SNF [6] and
the nuclear pore complex [7] raise the question concern-
ing how widespread might be the specific variance of
protein complex composition.Computational analysis of stable and variable
protein complexes
Several members of the same team that studied cell
type-specific nuclear pores asked this question in a new
study published in Genome Biology [8]. First, they built a
protein complex resource from several database sources,
including CORUM and COMPLEAT, that was then
filtered to contain 279 protein complexes that each
contains at least five distinct proteins, making a total of
2048 unique proteins. They then selected two large-scale
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lysis of mouse embryonic fibroblasts (MEFs) that had
been induced into pluripotent stem cells (iPSCs) [10].
These original articles [9, 10] are both well executed,
and detailed, quantitative proteomic studies, but it is im-
portant to bear in mind that they cover only a small
fraction of the total number of possible cellular states.
The authors then mapped the 279 protein complexes
onto these two quantitative proteomic datasets and
found that 182 were detected in one or the other of the
datasets, and of these 116 were observed in both. A siz-
able portion of protein complex members were differen-
tially expressed in both datasets, leading to the
description of stable or variable protein complexes.
Over half of the 182 protein complexes analyzed were
variable. More specifically, 102 of the complexes analyzed
were variable, and 80 were stable. Stable complexes
included the ribosome, the proteasome, mitochondrial
protein complexes, and the exosome. However, some vari-
ability was seen in the ribosome, consistent with emerging
evidence regarding the functional importance of special-
ized ribosomes [5]. By contrast, variable complexes
included those involved in mRNA transport, vesicle-
mediated transport and chromatin remodeling. Specific
examples of variable complexes include TREX, COPII,
COPI, SWI/SNF (BAF) and NuRD. From the quantitative
proteomics datasets analyzed on different human cell lines
[9], and iPSCs from MEFs [10], the major variable com-
plexes were epigenetic regulators and transport systems.
These observations raise questions concerning how
these variable complexes are regulated. Certainly, de-
tailed and focused studies on each of the complexes are
warranted in the future, but here the authors searched
for general principles. They focused on the induced plur-
ipotency dataset in mouse because gene expression data
were available. Fewer than half of the cases of variant
changes were likely attributable to transcriptional regula-
tion, where protein and transcript abundance changed in
the same direction at the same point in time. Almost
two-thirds of the cases appear to be regulation at the
level of translation or protein turnover. An analysis of
structures from the Protein Data Bank suggested that
stable interactions have structural properties different to
those of variable interactions. Specifically, the authors
suggest that variable interfaces are less hydrophobic than
stable interfaces and might be more accessible to regula-
tory events such as phosphorylation.
Paralog switching
Further analysis of the variable complexes revealed fre-
quent paralog switching, where paralogs are genes pro-
duced through gene duplication in a genome and in these
variable complexes one paralog would be replaced by an-
other under certain circumstances. In the reprogrammingdataset [10], the authors found 23 co-regulated paralog
pairs, 16 of which had similar abundance differences—but
in opposite directions. Two paralog switches found in the
SWI/SNF (BAF) complex were the same paralog
switches highlighted in a previous study showing the
importance of specialized subunit composition for stem
cell maintenance and pluripotency [6]. Additional re-
programming paralog switches occurred in the COPI,
COPII and SNARE complexes, and COPII also had two
paralog switches. The authors of the current study
found a paralog switch in the NuRD chromatin-
remodeling complex from the analysis of data from hu-
man cell lines [9]. A targeted proteomics analysis of
MBD3-containing NuRD complexes from HEK293 cells
verified their computational analysis.
Proteomics and genomic data existed for a limited
number of the paralog switches. The authors analyzed
these data to gain insight into the potential regulation of
these switches. In most cases, changes in protein and
transcript abundance correlated for one of the two para-
logs, but, in the case of the SWI/SNF (BAF) complex,
protein and transcript changes correlated for both para-
logs. This suggests that there are probably several mech-
anisms for controlling such paralog switches.
Concluding remarks
There is no single human interactome. There are many.
How they are different and regulated is crucial for their
understanding. Protein interaction networks are dy-
namic and context dependent. The differences in
networks between cellular states are probably deter-
mined by key regulatory mechanisms for controlling
these states. An excellent example reported in the re-
cent Genome Biology study [8], and in previous work, is
that of the SWI/SNF (BAF) complex and its importance
in cellular reprogramming [6]. While the authors of the
recent study [8] used two large-scale quantitative prote-
omic datasets, these studies represent a small fraction
of the possible proteomes that could be analyzed.
Development-, differentiation-, cell cycle-, normal- and
disease- and drug-induced networks are all systems
where variant complexes are likely to exist, and paralog
switching might be a key regulatory mechanism.
Clearly, how paralog switching itself is regulated will be
an important area of future research. The final intri-
guing analysis carried out by the authors was a compu-
tational test to see whether the abundance of variable
complex members can differentiate normal and cancer
tissues. In the single situation presented this approach
worked, but an analysis of a much larger scope,
covering many more tissues, is warranted. However, it
will be fascinating to see whether variable protein
complex content is able to discriminate normal and
diseased states.
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